LI YUN-LONG,ZHUO JINCONG,QIAN DING-QUAN,MEI SONG,CAO GANFENG,PAN YONGCHUN,LI QUN,JIA ZHONGJIANG
申请号：
PL14732705
公开号：
PL2997023T3
申请日:
2014.05.16
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
The present invention provides compounds of Formula I: or pharmaceutically acceptable salts thereof, as well as their compositions and methods of use, that inhibit the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
